Knowledge sharing and co-operation – Are these the key to a more certain future for pharmaceutical innovation?
29-30th April 2008, Surrey, UK
Altruism or enlightened self-interest – what are the drivers for a more open research environment for medicines?
Several of the workshops held by the CMR International Institute for Regulatory Science between 2003-2008 suggested ways that research into new medicines could benefit from a greater willingness to share the knowledge gained by the various stakeholders, above all where safety issues are involved.
This meeting was convened to take these discussions further and to look at the potential gains that more transparency would bring in terms of public perception of the pharma industry, the quality of regulation and, in particular, in increased patient safety and more efficient research.